Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Fluvoxamine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Fluvoxamine. |
| Citalopram | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Citalopram. |
| Fluoxetine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Fluoxetine. |
| Duloxetine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Duloxetine. |
| Trazodone | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Trazodone. |
| Paroxetine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Paroxetine. |
| Sertraline | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Sertraline. |
| Sibutramine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Sibutramine. |
| Nefazodone | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Nefazodone. |
| Escitalopram | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Escitalopram. |
| Zimelidine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Zimelidine. |
| Dapoxetine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Dapoxetine. |
| Milnacipran | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Milnacipran. |
| Desvenlafaxine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Desvenlafaxine. |
| Seproxetine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Seproxetine. |
| Indalpine | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Indalpine. |
| Ritanserin | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Ritanserin. |
| Alaproclate | The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Alaproclate. |
| Digoxin | The serum concentration of Digoxin can be increased when it is combined with Dibromotyrosine. |
| Acetyldigitoxin | The serum concentration of Acetyldigitoxin can be increased when it is combined with Dibromotyrosine. |
| Deslanoside | The serum concentration of Deslanoside can be increased when it is combined with Dibromotyrosine. |
| Ouabain | The serum concentration of Ouabain can be increased when it is combined with Dibromotyrosine. |
| Digitoxin | The serum concentration of Digitoxin can be increased when it is combined with Dibromotyrosine. |
| Oleandrin | The serum concentration of Oleandrin can be increased when it is combined with Dibromotyrosine. |
| Cymarin | The serum concentration of Cymarin can be increased when it is combined with Dibromotyrosine. |
| Proscillaridin | The serum concentration of Proscillaridin can be increased when it is combined with Dibromotyrosine. |
| Metildigoxin | The serum concentration of Metildigoxin can be increased when it is combined with Dibromotyrosine. |
| Lanatoside C | The serum concentration of Lanatoside C can be increased when it is combined with Dibromotyrosine. |
| Gitoformate | The serum concentration of Gitoformate can be increased when it is combined with Dibromotyrosine. |
| Acetyldigoxin | The serum concentration of Acetyldigoxin can be increased when it is combined with Dibromotyrosine. |
| Peruvoside | The serum concentration of Peruvoside can be increased when it is combined with Dibromotyrosine. |
| Iodide I-131 | The therapeutic efficacy of Iodide I-131 can be decreased when used in combination with Dibromotyrosine. |
| Lepirudin | Dibromotyrosine may increase the anticoagulant activities of Lepirudin. |
| Bivalirudin | Dibromotyrosine may increase the anticoagulant activities of Bivalirudin. |
| Alteplase | Dibromotyrosine may increase the anticoagulant activities of Alteplase. |
| Urokinase | Dibromotyrosine may increase the anticoagulant activities of Urokinase. |
| Reteplase | Dibromotyrosine may increase the anticoagulant activities of Reteplase. |
| Anistreplase | Dibromotyrosine may increase the anticoagulant activities of Anistreplase. |
| Tenecteplase | Dibromotyrosine may increase the anticoagulant activities of Tenecteplase. |
| Abciximab | Dibromotyrosine may increase the anticoagulant activities of Abciximab. |
| Drotrecogin alfa | Dibromotyrosine may increase the anticoagulant activities of Drotrecogin alfa. |
| Streptokinase | Dibromotyrosine may increase the anticoagulant activities of Streptokinase. |
| Dicoumarol | Dibromotyrosine may increase the anticoagulant activities of Dicoumarol. |
| Argatroban | Dibromotyrosine may increase the anticoagulant activities of Argatroban. |
| Ardeparin | Dibromotyrosine may increase the anticoagulant activities of Ardeparin. |
| Phenindione | Dibromotyrosine may increase the anticoagulant activities of Phenindione. |
| Fondaparinux | Dibromotyrosine may increase the anticoagulant activities of Fondaparinux. |
| Warfarin | Dibromotyrosine may increase the anticoagulant activities of Warfarin. |
| Pentosan polysulfate | Dibromotyrosine may increase the anticoagulant activities of Pentosan polysulfate. |
| Phenprocoumon | Dibromotyrosine may increase the anticoagulant activities of Phenprocoumon. |
| Dipyridamole | Dibromotyrosine may increase the anticoagulant activities of Dipyridamole. |
| Heparin | Dibromotyrosine may increase the anticoagulant activities of Heparin. |
| Enoxaparin | Dibromotyrosine may increase the anticoagulant activities of Enoxaparin. |
| Epoprostenol | Dibromotyrosine may increase the anticoagulant activities of Epoprostenol. |
| Acenocoumarol | Dibromotyrosine may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Dibromotyrosine may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Dibromotyrosine may increase the anticoagulant activities of Coumarin. |
| Ximelagatran | Dibromotyrosine may increase the anticoagulant activities of Ximelagatran. |
| Desmoteplase | Dibromotyrosine may increase the anticoagulant activities of Desmoteplase. |
| Defibrotide | Dibromotyrosine may increase the anticoagulant activities of Defibrotide. |
| Ancrod | Dibromotyrosine may increase the anticoagulant activities of Ancrod. |
| Beraprost | Dibromotyrosine may increase the anticoagulant activities of Beraprost. |
| Prasugrel | Dibromotyrosine may increase the anticoagulant activities of Prasugrel. |
| Rivaroxaban | Dibromotyrosine may increase the anticoagulant activities of Rivaroxaban. |
| Sulodexide | Dibromotyrosine may increase the anticoagulant activities of Sulodexide. |
| Semuloparin | Dibromotyrosine may increase the anticoagulant activities of Semuloparin. |
| Idraparinux | Dibromotyrosine may increase the anticoagulant activities of Idraparinux. |
| Cangrelor | Dibromotyrosine may increase the anticoagulant activities of Cangrelor. |
| Astaxanthin | Dibromotyrosine may increase the anticoagulant activities of Astaxanthin. |
| Apixaban | Dibromotyrosine may increase the anticoagulant activities of Apixaban. |
| Otamixaban | Dibromotyrosine may increase the anticoagulant activities of Otamixaban. |
| Amediplase | Dibromotyrosine may increase the anticoagulant activities of Amediplase. |
| Dabigatran etexilate | Dibromotyrosine may increase the anticoagulant activities of Dabigatran etexilate. |
| Danaparoid | Dibromotyrosine may increase the anticoagulant activities of Danaparoid. |
| Dalteparin | Dibromotyrosine may increase the anticoagulant activities of Dalteparin. |
| Tinzaparin | Dibromotyrosine may increase the anticoagulant activities of Tinzaparin. |
| (R)-warfarin | Dibromotyrosine may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Dibromotyrosine may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Nadroparin | Dibromotyrosine may increase the anticoagulant activities of Nadroparin. |
| Triflusal | Dibromotyrosine may increase the anticoagulant activities of Triflusal. |
| Ticagrelor | Dibromotyrosine may increase the anticoagulant activities of Ticagrelor. |
| Ditazole | Dibromotyrosine may increase the anticoagulant activities of Ditazole. |
| Vorapaxar | Dibromotyrosine may increase the anticoagulant activities of Vorapaxar. |
| Edoxaban | Dibromotyrosine may increase the anticoagulant activities of Edoxaban. |
| Sodium citrate | Dibromotyrosine may increase the anticoagulant activities of Sodium citrate. |
| Dextran | Dibromotyrosine may increase the anticoagulant activities of Dextran. |
| Bemiparin | Dibromotyrosine may increase the anticoagulant activities of Bemiparin. |
| Parnaparin | Dibromotyrosine may increase the anticoagulant activities of Parnaparin. |
| Desirudin | Dibromotyrosine may increase the anticoagulant activities of Desirudin. |
| Antithrombin Alfa | Dibromotyrosine may increase the anticoagulant activities of Antithrombin Alfa. |
| Protein C | Dibromotyrosine may increase the anticoagulant activities of Protein C. |
| Antithrombin III human | Dibromotyrosine may increase the anticoagulant activities of Antithrombin III human. |
| Letaxaban | Dibromotyrosine may increase the anticoagulant activities of Letaxaban. |
| Darexaban | Dibromotyrosine may increase the anticoagulant activities of Darexaban. |
| Betrixaban | Dibromotyrosine may increase the anticoagulant activities of Betrixaban. |
| Nafamostat | Dibromotyrosine may increase the anticoagulant activities of Nafamostat. |
| Monteplase | Dibromotyrosine may increase the anticoagulant activities of Monteplase. |
| Gabexate | Dibromotyrosine may increase the anticoagulant activities of Gabexate. |
| Fluindione | Dibromotyrosine may increase the anticoagulant activities of Fluindione. |
| Protein S human | Dibromotyrosine may increase the anticoagulant activities of Protein S human. |